相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of intraperitoneally administered resveratrol against rat orthotopic ovarian cancers
Li-Xia Zhong et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Anti-tumor effects of resveratrol on malignant melanoma is associated with promoter demethylation of RUNX3 gene
Sisi Kang et al.
PHARMAZIE (2019)
Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors
Tsung-Han Hsieh et al.
NEURO-ONCOLOGY (2018)
DNA methylation status of CRABP2 promoter down-regulates its expression
Gui-Min Zhang et al.
GENE (2018)
Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells
Yi-Tian Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells
Xu Zheng et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Preventive Potential of Resveratrol in Carcinogen-Induced Rat Thyroid Tumorigenesis
Xu Zheng et al.
NUTRIENTS (2018)
Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas
Xue Song et al.
BMC CANCER (2018)
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies
Eleonora Molinaro et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
PD-L1 promoter methylation mediates the resistance response to anti-PD-1 therapy in NSCLC patients with EGFR-TKI resistance
Yan Zhang et al.
ONCOTARGET (2017)
Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study
Nilofer S. Azad et al.
ONCOTARGET (2017)
Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes
Ashwin Unnikrishnan et al.
CELL REPORTS (2017)
DNA Hypomethylating Drugs in Cancer Therapy
Takahiro Sato et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Clinical and biological effects of demethylating agents on solid tumours - A systematic review
J. F. Linnekamp et al.
CANCER TREATMENT REVIEWS (2017)
Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells
Vivien Koh et al.
BMC GENOMICS (2016)
Association Between Cytoplasmic CRABP2, Altered Retinoic Acid Signaling, and Poor Prognosis in Glioblastoma
Rong-Zong Liu et al.
GLIA (2016)
Resveratrol and STAT inhibitor enhance autophagy in ovarian cancer cells
L-X Zhong et al.
CELL DEATH DISCOVERY (2016)
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications
Xiao-Hong Shu et al.
NEUROTHERAPEUTICS (2015)
Anaplastic Thyroid Cancer: Outcome and the Mutation/Expression Profiles of Potential Targets
Hao Wu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells
Daoyang Zhou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Short-Term Resveratrol Exposure Causes In Vitro and In Vivo Growth Inhibition and Apoptosis of Bladder Cancer Cells
Mo-Li Wu et al.
PLOS ONE (2014)
Expression and clinical significance of CRABP1 and CRABP2 in non-small cell lung cancer
Irina Favorskaya et al.
TUMOR BIOLOGY (2014)
Molecular Determinants of Retinoic Acid Sensitivity in Pancreatic Cancer
Sonal Gupta et al.
CLINICAL CANCER RESEARCH (2012)
CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells
Nan-Nan Chen et al.
EXPERIMENTAL DERMATOLOGY (2012)
Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas
Benito Campos et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor
Steven G. Gray et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Multifaceted suppression of aggressive behavior of thyroid carcinoma by all-trans retinoic acid induced re-differentiation
Mohsen Malehmir et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma
Yuan-Shan Fu et al.
MOLECULAR ONCOLOGY (2012)
Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer
Jian Yang et al.
MOLECULAR MEDICINE REPORTS (2011)
Pipeline for Large-Scale Microdroplet Bisulfite PCR-Based Sequencing Allows the Tracking of Hepitype Evolution in Tumors
Alexander Herrmann et al.
PLOS ONE (2011)
DNA methylation as a universal biomarker
Victor V. Levenson
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2010)
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
Giovanni L. Gravina et al.
MOLECULAR CANCER (2010)
Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: basics and first clinical results
D. Simon et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Massive parallel bisulfite sequencing of CG-rich DNA fragments reveals that methylation of many X-chromosomal CpG islands in female blood DNA is incomplete
Michael Zeschnigk et al.
HUMAN MOLECULAR GENETICS (2009)
Epigenetic Silencing of CRABP2 and MX1 in Head and Neck Tumors
Marilia F. Calmon et al.
NEOPLASIA (2009)
Carcinogen-induced Gene Promoter Hypermethylation Is Mediated by DNMT1 and Causal for Transformation of Immortalized Bronchial Epithelial Cells
Leah A. Damiani et al.
CANCER RESEARCH (2008)
Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells
Li-Jun Yu et al.
NEOPLASIA (2008)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
DNA methylation profiling of human chromosomes 6, 20 and 22
Florian Eckhardt et al.
NATURE GENETICS (2006)
Defective efficacy of retinoic acid treatment in patients with metastatic thyroid carcinoma
F. Courbon et al.
THYROID (2006)
Anaplastic thyroid carcinoma: Biology, pathogenesis, prognostic factors, and treatment approaches
C Are et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells
M Suzuki et al.
CANCER RESEARCH (2004)
DNA methylation patterns and epigenetic memory
A Bird
GENES & DEVELOPMENT (2002)
Retinoic acid redifferentiation therapy for thyroid cancer
C Schmutzler et al.
THYROID (2000)
分享论文
